WEDNESDAY, April 19, 2023 (HealthDay News) Vaginal sampling should be the initial choice offered to patients undergoing testing for chlamydia, gonorrhea, and/or trichomoniasis, according to a systematic review and meta-analysis published in the March/April issue of the Annals of Family Medicine. Kristal J. Aaron, Dr.P.H., from the University of Alabama at Birmingham, and colleagues
Researchers identified 28 eligible articles with 30 comparisons for Chlamydia trachomatis, 16 comparisons for Neisseria gonorrhoeae, and 9 comparisons for Trichomonas vaginalis.
Evidence from nearly 30 studies support vaginal swabs as the optimal specimen for chlamydia and gonorrhea testing rather than urine samples, with the latter representing a “disservice” with long-term consequences, according to researchers. Kristal J. Aaron, DrPH, MSPH, BS, a clinical data manager at the University of Alabama at Birmingham, and colleagues wrote in Annals of Family